IL6 and Glucose intolerance: Additionally, in vivo studies showed that asprosin increased endoplasmic reticulum stress, glucose intolerance, insulin resistance, and the flow of pro-inflammatory cytokines (monocyte chemoattractant protein-1, IL-6, and TNF) [23].